Department of Medicine, Beth Israel Medical Center, University Hospital and Manhattan Campus for the Albert Einstein College of Medicine, New York, New York, USA.
Am J Cardiol. 2010 Mar 1;105(5):629-32. doi: 10.1016/j.amjcard.2009.10.043.
A weight-adjusted bolus of heparin (70 to 100 IU/kg) is recommended to achieve adequate anticoagulation during percutaneous coronary intervention (PCI). Proper dosing is mandatory to avoid bleeding and thrombotic complications. We investigated whether sensitivity to heparin is affected by difference in race. We performed a retrospective study with 874 consecutive PCI cases in our catheterization laboratory. The amount of initial heparin bolus (international units) per weight and subsequent activated clotting time (ACT; seconds) were obtained. Patients were divided into 4 categories based on race: Asian, African-American, European-American, and Hispanic. Multiple regression analysis was performed to validate the variables that determine the ACT. After adjusting for these variables, analysis of variance revealed the presence of a significant racial difference in ACT (p = 0.002). Successively, Student-Newman-Keuls test and Bonferroni t test revealed that Asian patients have higher ACT levels compared to other racial groups (p <0.03 for Asian vs others, p >0.26 between non-Asian groups). There was a positive relation between ACT and Asian race (p = 0.0004). Further analyses showed that Asians require 10 IU/kg less heparin per weight than other racial groups to achieve the same goal of ACT. In conclusion, decreased heparin dosing should be considered for Asian patients undergoing PCI.
建议在经皮冠状动脉介入治疗(PCI)期间,根据体重给予调整剂量的肝素(70-100IU/kg)以达到充分抗凝。适当的剂量是避免出血和血栓并发症的必要条件。我们研究了肝素敏感性是否因种族差异而受到影响。我们对导管室 874 例连续 PCI 病例进行了回顾性研究。获得初始肝素推注量(单位)和随后的激活凝血时间(ACT;秒)。根据种族将患者分为 4 类:亚洲人、非裔美国人、欧裔美国人和西班牙裔。进行多元回归分析以验证确定 ACT 的变量。在调整这些变量后,方差分析显示 ACT 存在显著的种族差异(p = 0.002)。然后,学生新曼-凯斯检验和 Bonferroni t 检验显示亚洲患者的 ACT 水平高于其他种族组(亚洲与其他种族组相比,p <0.03,非亚洲种族组之间,p >0.26)。ACT 与亚洲种族之间存在正相关关系(p = 0.0004)。进一步分析表明,亚洲人在进行 PCI 时,每公斤体重需要的肝素剂量比其他种族少 10IU/kg 即可达到相同的 ACT 目标。总之,对于接受 PCI 的亚洲患者,应考虑减少肝素剂量。